Лерканидипин – антагонист кальция III поколения: обзор эффективности в терапии артериальной гипертензии
Аннотация
Об авторах
В. С. ЗадионченкоРоссия
Г. Г. Шехян
Россия
А. А. Ялымов
Россия
С. И. Варенцов
Россия
Список литературы
1. Bang L, Chapman T, Goa K. Lercanidipine – a review of its efficacy in management of hypertension. Drugs 2003; 22: 2449–72.
2. Cherubini A, Fabris F, Ferrari E et al. Comparative effects of lercanidipine, lacidipine and nifidepine GITS on blood pressure and heart rate in elderly hypertensive patients: the ELderly and LErcanidipine (ELLE) study. Arch Gerontol Geriatr 2003; 3: 203–12.
3. Zanchetti A. Emerging data on calcium - channel blockers: the COHORT study. Clin Cardiol 2003; 26 (Suppl. 2): II 17–20.
4. Toyo-Oka T, Nayler W.G. Third generation calcium entry blockers. Blood Pressure 1996; 5: 206–8.
5. Acanfora D, Trojano L, Gheorghiade M et al. A randomized, double - blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability. Am J Ther 2002; 9 (5): 444–53.
6. Barbagallo M, Sangiorgi G.B. Efficacy and tolerability of lercanidipine in monotherapy in elderly patients with isolated systolic hypertension. Aging Clin Exp Res 2000; 12 (5): 375–9.
7. Borghi С, Prandin M.G, Dormi A et al. The use of lercanidipine can improve the individual tolerability in dihydropyridine calcium blockers in hypertensive patients. J Hypertenmsion 2000; 18 (Suppl. 2): S155–S156.
8. Fogari R, Mugellini A, Zoppi A et al. Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension. Am J Hypertens 2003; 16 (7): 596–9.
9. Morisco C, Trimarco B. Efficacy and tolerability of lercanidipine in comparison and in combination with atenolol in patients with mild to moderate hypertension in double - blind controlled study. J Cardiovascul Pharmacol 1997; 29 (Suppl. 2): S26–S30.
10. Paterna S, Licata A, Arnone S et al. Lercanidipine in two different dosage regimens as a sole treatment for severe essential hypertension. J Cardiovascul Pharmacol 1997; 29 (Suppl. 2): S50–S53.
11. Policicchio D, Magliocca R, Malliani A. Efficacy and tolerability of lercanidipine in comparison and in combination with atenolol in patients with mild to moderate essential hypertension: a comparative study with slow - release nifedipine. J Cardiovascul Pharmacol 1997; 29 (Suppl. 2): S31–S35.
12. Romito R, Pansini M, Perticone F et al. Comparative effect of lercanidipine, felodipine and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: The Lercanidipine in Adults (LEAD) Study. J Clin Hyprtens 2003; 5 (4): 249–53.
Рецензия
Для цитирования:
Задионченко В.С., Шехян Г.Г., Ялымов А.А., Варенцов С.И. Лерканидипин – антагонист кальция III поколения: обзор эффективности в терапии артериальной гипертензии. Системные гипертензии. 2013;10(4):76-79.
For citation:
Zadionchenko V.S., Shekhyan G.G., Yalymov A.A., Varentsov S.I. Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment. Systemic Hypertension. 2013;10(4):76-79.
Послать статью по эл. почте 